Regulation of epidermal growth factor receptor levels by 1,25-dihydroxyvitamin d3 in human breast cancer cells

Cancer Research

Volumn 48, Issue 10, 1988, Pages 2734-2739

  Koga, Masafumi ^a,b   Eisman, John A ^a   Sutherland, Robert L ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b OSAKA UNIVERSITY HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CALCITRIOL; EPIDERMAL GROWTH FACTOR RECEPTOR; RADIOISOTOPE;

BREAST CANCER; CELL CULTURE; HUMAN; HUMAN CELL; TUMOR CELL LINE;

BREAST NEOPLASMS; CALCITRIOL; FEMALE; GROWTH HORMONE; HUMAN; PROGESTATIONAL HORMONES; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTORS, CALCITRIOL; RECEPTORS, STEROID; SUPPORT, NON-U.S. GOV'T; TUMOR CELLS, CULTURED;

EID: 0023886416     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. 3, in fetal bone. Science (Wash. DC), 197: 1086-1088, 1977.
2. Norman, A. W., Roth, J., and Orci, L. The vitamin D endocrine system: Steroid metabolism, hormone receptors, and biological response (calcium binding proteins). Endocrinol. Rev., 3: 331-366, 1982.
3. 3, and malignant melanoma: The presence of receptors and inhibition of cell growth in culture. Endocrinology, 108: 1083-1086, 1981.
4. 3. Proc. Natl. Acad. Sci. USA, 78: 4990-4994, 1981.
5. 3, metabolites. Cancer Res., 43: 4443-4447, 1983.
6. 3, inhibits the clonogenic growth of transformed cells via its receptor. Biochem. Biophys. Res. Commun., 139: 136-143, 1986.
7. 3, Cancer Res., 47: 21-25, 1987.
8. Eisman, J. A., Martin, T. J., Maclntyre, I., and Moseley, J. M. 1, 25-Dihydroxyvitamin D receptor in breast cancer cells. Lancet, 2: 1335-1336, 1979.
9. 3 receptor in a cultured human breast cancer cell line (MCF-7). Biochem. Biophys. Res. Commun., 93: 9-15, 1980.
10. 3, receptors in human breast cancer cell lines. Cancer Res., 40: 4764-4767, 1980.
11. 3 specifically binds to human breast cancer cell line (T-47D) and stimulates growth. Biochem. Biophys. Res. Commun., 101: 1131-1138, 1981.
12. 3 receptors in established human cancer cell lines in culture. Cancer Res., 42: 1116-1119, 1982.
13. Baxter, R. C., Maitland, J. E., Raison, R. L., Reddel, R. R., and Sutherland, R. L. High molecular weight somatomedin-C/IGF-I from T-47D human mammary carcinoma cells: Immunoreactivity and bioactivity. In: E. M. Spencer (ed.). Insulin-like Growth Factors/Somatomedins, pp. 615-618. Berlin: Walter de Gruyter Co., 1983.
14. Salomon, D. S., Zwiebel, J. A., Bano, M., Losonczy, I., Felnel, P., and Kidwell, W. R. Presence of transforming growth factors in human breast cancer cells. Cancer Res., 44: 4069-4077, 1984.
15. Dickson, R. B., Huff, K. K. Spencer, E. M., and Lippman, M. E. Induction of epidermal growth factor-related polypeptides by 17β-estradiol in MCF-7 human breast cancer cells. Endocrinology, 118: 138-142, 1985.
16. Dickson, R. B., Bates, S. E., McManaway, M. E., and Lippman, M. E. Characterization of estrogen responsive transforming activity in human breast cancer cell lines. Cancer Res., 46: 1707-1713, 1986.
17. Huff, K. K., Kaufman, D., Gabbay, K. H., Spencer, E. M., Lippman, M. E., and Dickson, R. B. Secretion of an insulin-like growth factor-I-related protein by human breast cancer cells. Cancer Res., 46: 4613-4619, 1986.
18. Dickson, R. B., and Lippman, M. E. Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocrinol. Rev., 8: 29-43, 1987.
19. Knabbe, C., Lippman, M. E., Makefield, L. M., Flanders, K. C., Kasid, A., Derynck, R., and Dickson, R. B. Evidence that transforming growth factorβ is a hormonally regulated negative growth factor in human breast cancer cells. Cell, 48: 417-428, 1987.
20. Murphy, L. J., Sutherland, R. L., and Lazarus, L. Regulation of growth hormone and epidermal growth factor receptors by progestins in breast cancer cells. Biochem. Biophys. Res. Commun., 131: 767-773, 1985.
21. Murphy, L. J., Sutherland, R. L., Stead, B., Murphy, L. C., and Lazarus, L. Progestin regulation of epidermal growth factor receptor in human mammary carcinoma cells. Cancer Res., 46: 728-734, 1986.
22. Chapman, R. E., Renwick, A. G. C., and Liversey, J. H. The isolation of human pituitary hormones from frozen gland. J. Clin. Endocrinol. Metab., 53: 1008-1013, 1981.
23. Reddel, R. R., Murphy, L. C., and Sutherland, R. L. Differential sensitivity of human breast cancer cell lines to the growth-inhibitory effects of tamoxifen. Cancer Res., 45: 1525-1531, 1985.
24. Murphy, L. J., Vrhovsek, E., Sutherland, R. L., and Lazarus, L. Growth hormone binding to cultured human breast cancer cells. J. Clin. Endocrinol. Metab., 58: 149-156, 1984.
25. Ketelalegers, J. M., Knott, G. D., and Catt, K. J. Kinetics of gonadotrophin binding by receptors of the rat testis. Analysis by a nonlinear curve-fitting method. Biochemistry, 14: 3075-3081, 1975.
26. Scatchard, G. The attractions of proteins for small molecules and ions. Ann. NY Acad. Sci., 51: 660-665, 1949.
27. Murphy, L. J., Murphy, L. C., Stead, B., Sutherland, R. L., and Lazarus, L. Modulation of lactogenic receptors by progestins in cultured human breast cancer cells. J. Clin. Endocrinol. Metab., 62: 280-287, 1986.
28. Imai, Y., Leung, C. K. H., Friesen, H. G., and Shiu, R. P. C. Epidermal growth factor receptors and effect of epidermal growth factor on growth of human breast cancer cells in long-term tissue culture. Cancer Res., 42: 4394-4398, 1982.
29. Fitzpatrick, S. L., La Chance, M. P., and Schultz, G. S. Characterization of epidermal growth factor receptor and action on human breast cancer cells in culture. Cancer Res., 44: 3442-3447, 1984.
30. 3: A novel immunoregulatory hormone. Science (Wash. DC), 224: 1438-1440, 1984.
31. 3. Proc. Natl. Acad. Sci. USA, 80: 5907-5911, 1983.
32. 3, Clin, endocrinol., 13: 267-272, 1980.
33. Sher, E., Eisman, J. E., Moseley, J. M., and Martin. T. J. Whole-cell uptake and nuclear localization of 1,25-dihydroxycholecalciferol by breast cancer cells (T47 D) in culture. Biochem. J., 200: 315-320, 1981.
34. Vignon, F., Bardon, S., Chalbos, D., and Rochefort, H. Antiestrogenic effect of R5020, a synthetic progestin in human breast cancer cells in culture. J. Clin. Endocr. Metab., 56: 1124-1130, 1983.
35. 00 human breast cancer cells by progestins: Implications for endocrine therapies. Cancer Res., 45: 167-173, 1985.
36. Sainsbury, J. R. C., Farndon, J. R., Sherbet, G. V., and Harris, A. L. Epidermal-growth-factor receptors and oestrogen receptors in human breast cancer. Lancet, 1: 364-366, 1985.
37. Davidson, N. E., Gelmann, E. P., Lippman, M. E., and Dickson, R. B. Epidermal growth factor receptor gene expression in estrogen receptorpositive and -negative human breast cancer cell lines. Mol. Endocrinol., 1: 216-223, 1987.
38. Filmus, J., Pollak, M. N., Cailleau, R., and Bruick, R. N. MDA-468, a human breast cancer cell line with a high number of epidermal growth factor (EGF) receptors, has an amplified EGF receptor gene and is growth inhibited by EGF. Biochem. Biophys. Res. Commun., 128: 898-905, 1985.
39. Huberman, E., and Callahan, M. Induction of terminal differentiation in human promyelocytic leukemia cells by tumor-promoting agents. Proc. Natl. Acad. Sci. USA, 76: 1293-1297, 1979.
40. Breitmen, T. R., Selonick, S. E., and Collins, S. J. Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinole acid. Proc. Natl. Acad. Sci. USA, 77: 2936-2940, 1980.